Paracetamol poisoning: beyond the nomogram

Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.

[1]  D. Webb,et al.  Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment , 2014, British journal of clinical pharmacology.

[2]  P. Watkins,et al.  Keratin‐18 and microRNA‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[3]  D. Webb,et al.  Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial , 2014, The Lancet.

[4]  J. Dear,et al.  Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges , 2014, Expert review of clinical pharmacology.

[5]  Alasdair J Gray,et al.  Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital , 2013, Hepatology.

[6]  D. Webb,et al.  Scottish and Newcastle Antiemetic Pre-treatment for paracetamol poisoning study (SNAP) , 2013, BMC Pharmacology and Toxicology.

[7]  J. Caro,et al.  Treating acetaminophen overdose: thresholds, costs and uncertainties , 2013, Clinical toxicology.

[8]  B. Rumack,et al.  Acetaminophen and acetylcysteine dose and duration: Past, present and future , 2012, Clinical toxicology.

[9]  D. Webb,et al.  Cyclophilin A Is a Damage-Associated Molecular Pattern Molecule That Mediates Acetaminophen-Induced Liver Injury , 2011, The Journal of Immunology.

[10]  J. Dear,et al.  Management of paracetamol poisoning , 2011, BMJ : British Medical Journal.

[11]  D. Juurlink,et al.  When do the aminotransferases rise after acute acetaminophen overdose? , 2010, Clinical toxicology.

[12]  I. Stiell,et al.  Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. , 2009, Annals of emergency medicine.

[13]  E. Sandilands,et al.  Adverse reactions associated with acetylcysteine , 2009, Clinical toxicology.

[14]  W. Waring,et al.  Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit , 2009, European Journal of Clinical Pharmacology.

[15]  W. Waring,et al.  Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose , 2008, Clinical toxicology.

[16]  Sushma Sharma,et al.  Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose , 2008, Clinical toxicology.

[17]  M. Hudson,et al.  Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. , 2006, QJM : monthly journal of the Association of Physicians.

[18]  D. Juurlink,et al.  A New Predictor of Toxicity Following Acetaminophen Overdose Based on Pretreatment Exposure , 2005, Clinical toxicology.

[19]  A. Proudfoot,et al.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage , 2004, European Journal of Clinical Pharmacology.

[20]  D. Reith,et al.  Acetaminophen Causes an Increased International Normalized Ratio by Reducing Functional Factor VII , 2000, Therapeutic drug monitoring.

[21]  G. D. Johnston,et al.  Paracetamol (acetaminophen) poisoning: no need to change current guidelines to accident departments , 2016 .

[22]  K. Kulig,et al.  Adverse reactions to N‐acetylcysteine , 1989, The Medical journal of Australia.

[23]  G. Knapp,et al.  Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) , 1988, The New England journal of medicine.

[24]  V. Beral,et al.  PREGNANCY OUTCOME IN INSULIN-DEPENDENT DIABETICS WITH THYROID DISEASE OR PERNICIOUS ANAEMIA , 1984, The Lancet.

[25]  J. Critchley,et al.  Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning. , 1979, British medical journal.

[26]  Nigel Walton,et al.  ANAPHYLACTOID REACTION TO N-ACETYLCYSTEINE , 1979, The Lancet.

[27]  P. Crome,et al.  Intravenous N-acetylcysteine: the treatment of choice in paracetamol poisoning? , 1979, British medical journal.

[28]  Prescott Lf.  The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage. , 1978 .

[29]  L. Prescott.  The chief scientist reports ... prevention of hepatic necrosis following paracetamol overdosage. , 1978, Health bulletin.

[30]  A. Proudfoot,et al.  TREATMENT OF PARACETAMOL (ACETAMINOPHEN) POISONING WITH N-ACETYLCYSTEINE , 1977, The Lancet.

[31]  G. Sutherland,et al.  CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING , 1976, The Lancet.

[32]  B. Rumack,et al.  Acetaminophen poisoning and toxicity. , 1975, Pediatrics.

[33]  G. Hall,et al.  MALIGNANT HYPERTHERMIA: A HUMAN AND PORCINE STRESS SYNDROME? , 1975, The Lancet.

[34]  S. Thorgeirsson,et al.  Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy , 1974, Clinical pharmacology and therapeutics.

[35]  R. Newton,et al.  Successful treatment of severe paracetamol overdosage with cysteamine. , 1974, Lancet.

[36]  S. Thorgeirsson,et al.  Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.

[37]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[38]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[39]  L. Prescott,et al.  Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. , 1971, Lancet.

[40]  D. Davidson,et al.  Acute liver necrosis following overdose of paracetamol. , 1966, British medical journal.

[41]  L. Prescott,et al.  Liver damage and impaired glucose tolerance after paracetamol overdosage. , 1966, British medical journal.

[42]  Braimbridge Mv.  HAEMOLYTIC ANAEMIA AND ACUTE RENAL DISEASE. , 1965 .

[43]  J. G. Thomson,et al.  MECHANICAL TRANSMISSION OF TRYPANOSOMIASIS, LEISHMANIASIS, AND YAWS THROUGH THE AGENCY OF NON-BITING HAEMATOPHAGOUS FLIES , 1934, British medical journal.